vorasidenib
servier
['vorasidenib', 'indigo']
excellent presentation from md. mellinghoff about indigo clinical trial. tx with vorasidenib significantly improved imaging based pfs (27.7 m vs 11.1 mo) in pts with diffuse gliomas with idh 1/2 mutations. and ttni with a manageable safety profile. #asco23 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.